Concenter Biopharma of Jerusalem is developing a drug to treat and even prevent type 2 diabetes by restoring the body’s insulin sensitivity.

Finally, a pill that could fix the root cause of diabetes

By ISRAEL21c —— Bio and Archives--January 17, 2020

Health and Medicine | Comments | Back To Full Article

Of the 463 million people in the world with diabetes, up to 95 percent have type 2 (T2D). In T2D, peripheral tissues – mostly muscles — are resistant to insulin, a hormone made by the pancreas to stabilize blood-sugar levels and enable the body to use and store sugar. Medications available today treat the symptoms and complications of T2D but do not solve the core problem of insulin resistance.

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Comments

---

Support Canada Free Press

---

---

Recommended by Canada Free Press

---

---

---